Nuclear Medicine Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application (Cardiology, Neurology, Oncology), By End Use (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Market Segmentation
- Nuclear Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Nuclear Medicine Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Nuclear Medicine End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Centers
- Others
- Nuclear Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- North America Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- North America Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- U.S.
- U.S. Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- U.S. Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- U.S. Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- U.S. Nuclear Medicine Market, By Product
- Canada
- Canada Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Canada Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Canada Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Canada Nuclear Medicine Market, By Product
- Mexico
- Mexico Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Mexico Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Mexico Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Mexico Nuclear Medicine Market, By Product
- North America Nuclear Medicine Market, By Product
- Europe
- Europe Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Europe Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Europe Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Germany
- Germany Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Germany Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Germany Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Germany Nuclear Medicine Market, By Product
- U.K.
- U.K. Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- U.K. Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- U.K. Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- U.K. Nuclear Medicine Market, By Product
- France
- France Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- France Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- France Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- France Nuclear Medicine Market, By Product
- Italy
- Italy Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Italy Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Italy Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Italy Nuclear Medicine Market, By Product
- Spain
- Spain Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Spain Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Spain Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Spain Nuclear Medicine Market, By Product
- Denmark
- Denmark Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Denmark Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Denmark Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Denmark Nuclear Medicine Market, By Product
- Sweden
- Sweden Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Sweden Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Sweden Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Sweden Nuclear Medicine Market, By Product
- Norway
- Norway Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Norway Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Norway Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Norway Nuclear Medicine Market, By Product
- Europe Nuclear Medicine Market, By Product
- Asia Pacific
- Asia Pacific Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Asia Pacific Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Asia Pacific Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- China
- China Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- China Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- China Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- China Nuclear Medicine Market, By Product
- Japan
- Japan Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Japan Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Japan Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Japan Nuclear Medicine Market, By Product
- India
- India Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- India Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- India Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- India Nuclear Medicine Market, By Product
- South Korea
- South Korea Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- South Korea Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- South Korea Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- South Korea Nuclear Medicine Market, By Product
- Australia
- Australia Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Australia Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Australia Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Australia Nuclear Medicine Market, By Product
- Thailand
- Thailand Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Thailand Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Thailand Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Thailand Nuclear Medicine Market, By Product
- Asia Pacific Nuclear Medicine Market, By Product
- Latin America
- Latin America Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Latin America Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Latin America Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Brazil
- Brazil Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Brazil Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Brazil Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Brazil Nuclear Medicine Market, By Product
- Argentina
- Argentina Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Argentina Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Argentina Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Argentina Nuclear Medicine Market, By Product
- Latin America Nuclear Medicine Market, By Product
- Middle East and Africa (MEA)
- Middle East and Africa (MEA) Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Middle East and Africa (MEA) Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Middle East and Africa (MEA) Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- South Africa
- South Africa Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- South Africa Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- South Africa Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- South Africa Nuclear Medicine Market, By Product
- Saudi Arabia
- Saudi Arabia Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Saudi Arabia Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Saudi Arabia Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Saudi Arabia Nuclear Medicine Market, By Product
- Kuwait
- Kuwait Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- Kuwait Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- Kuwait Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- Kuwait Nuclear Medicine Market, By Product
- UAE
- UAE Nuclear Medicine Market, By Product
- Diagnostics
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Others
- PET
- F-18
- SR-82/RB-82
- PYLARIFY (piflufolastat F 18)
- Illuccix (gallium Ga 68 gozetotide)
- Others
- SPECT
- Therapeutics
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-177
- Others
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
- Alpha Emitters
- Diagnostics
- UAE Nuclear Medicine Market, By Application
- Cardiology
- SPECT
- PET
- Therapeutic Applications
- Neurology
- Oncology
- Thyroid
- SPECT
- Therapeutic Applications
- Lymphoma
- Bone Metastasis
- SPECT
- Therapeutic Applications
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Cardiology
- UAE Nuclear Medicine Market, By End Use
- Hospitals
- Diagnostic Centers
- Others
- UAE Nuclear Medicine Market, By Product
- Middle East and Africa (MEA) Nuclear Medicine Market, By Product
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
